Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Proliferative changes in chemoprevention trials: learning from secondary endpoints.

Szabo E.

J Natl Cancer Inst. 2007 Nov 7;99(21):1565-7. Epub 2007 Oct 30. No abstract available.

2.

Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.

Hittelman WN, Liu DD, Kurie JM, Lotan R, Lee JS, Khuri F, Ibarguen H, Morice RC, Walsh G, Roth JA, Minna J, Ro JY, Broxson A, Hong WK, Lee JJ.

J Natl Cancer Inst. 2007 Nov 7;99(21):1603-12. Epub 2007 Oct 30.

3.

[Expression of Ki-67 in bronchial asthma].

Grigoraş CC, Grigoraş A, Mihăescu T, Vereş L, Carasevici E.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1034-9. Romanian.

PMID:
20191870
4.

An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.

Kim ES, Hong WK.

J Natl Cancer Inst. 2005 Apr 6;97(7):468-70. Review. No abstract available.

5.

Chemoprevention of tocotrienols: the mechanism of antiproliferative effects.

Wada S.

Forum Nutr. 2009;61:204-16. doi: 10.1159/000212752. Epub 2009 Apr 7. Review.

PMID:
19367124
6.

Lung epithelial proliferation: a biomarker for chemoprevention trials?

Szabo E.

J Natl Cancer Inst. 2001 Jul 18;93(14):1042-3. No abstract available.

7.

Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.

Peternac D, Klima I, Cecchini MG, Schwaninger R, Studer UE, Thalmann GN.

Prostate. 2008 Sep 1;68(12):1307-18. doi: 10.1002/pros.20795.

PMID:
18512728
8.

Chemoprevention of colorectal cancer-experimental and clinical aspects-.

Takayama T, Goji T, Taniguchi T, Inoue A.

J Med Invest. 2009 Feb;56(1-2):1-5. Review.

9.

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice.

Wentz SC, Wu H, Yip-Schneider MT, Hennig M, Klein PJ, Sebolt-Leopold J, Schmidt CM.

J Gastrointest Surg. 2008 Jan;12(1):30-7. Epub 2007 Nov 7.

PMID:
17987349
10.
11.

Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.

Cordes C, Münzel AK, Rudolph P, Hoffmann M, Leuschner I, Gottschlich S.

Anticancer Res. 2009 Apr;29(4):1459-65.

12.

Chemoprevention of breast and prostate cancers: where do we stand?

Senn HJ, Morant R.

Ann Oncol. 2008 Sep;19 Suppl 7:vii234-7. doi: 10.1093/annonc/mdn470. No abstract available.

13.

Lessons learned from lung cancer chemoprevention trials.

Kim ES.

Nat Clin Pract Oncol. 2009 Jan;6(1):1. doi: 10.1038/ncponc1293. No abstract available.

PMID:
19096395
14.

Cancer chemoprevention: how do we know what works?

Neugut AI, Lebwohl B, Hershman DL.

J Clin Oncol. 2007 Apr 20;25(12):1461-2. No abstract available.

15.

Apoptosis in psoriatic epidermis.

Heenen M, Simonart T.

J Cutan Pathol. 2008 Mar;35(3):346. doi: 10.1111/j.1600-0560.2007.00795.x. No abstract available.

PMID:
18251754
16.

Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.

Jamali M, Chetty R.

Endocr Pathol. 2008 Winter;19(4):282-8. doi: 10.1007/s12022-008-9044-0. Review.

PMID:
18931958
17.

Terpenoids and breast cancer chemoprevention.

Rabi T, Bishayee A.

Breast Cancer Res Treat. 2009 May;115(2):223-39. doi: 10.1007/s10549-008-0118-y. Epub 2008 Jul 19. Review.

PMID:
18636327
18.

Optimizing the implementation of future treatment using surrogate end-points.

Dowsett M.

Breast Cancer Res. 2008;10 Suppl 4:S26. doi: 10.1186/bcr2186. Epub 2008 Dec 18. No abstract available.

19.

Endometrium from women with endometriosis shows increased proliferation activity.

Park JS, Lee JH, Kim M, Chang HJ, Hwang KJ, Chang KH.

Fertil Steril. 2009 Oct;92(4):1246-9. doi: 10.1016/j.fertnstert.2009.04.025. Epub 2009 Jun 6.

PMID:
19501353
20.

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Gusterson BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS; International Breast Cancer Study Group.

J Natl Cancer Inst. 2008 Feb 6;100(3):207-12. doi: 10.1093/jnci/djm289. Epub 2008 Jan 29.

Items per page

Supplemental Content

Write to the Help Desk